Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for heart rate control and hemodynamics in sepsis
ChiCTR2300071410Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ivabradine in sepsis (2 arms), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Heart rate, Blood pressure and 9 more. Planned start May 2023; status: not yet recruiting.
02
Drugs
ivabradine
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR2300071410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071410.